The global point of care diagnostics market valued at US$ 14.26 billion in 2023, is forecasted to grow at a robust CAGR of 8.5%, reaching US$ ...

Advancements and Projections in the Medical Blood Lancet Market: Insights, Trends, Opportunities, and Recent DevelopmentsNew ...

Samsung might be the first to crack the non-invasive blood glucose monitoring code, but gaining FDA approval will be the ...

Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced compelling ...

With continuous glucose monitors, students with Type 1 diabetes no longer have to visit the school nurse for a finger prick. But some parents say it falls to them to keep an eye on blood sugar levels ...

Samsung Nears Breakthrough in Non-Invasive Glucose Monitoring Samsung is on the verge of revolutionizing wearable health ...

This study reinforces the significance of intensive glycaemic control and is a paradigm shift in managing the disease and its ...

With a solid foundation for growth and a promising outlook, the global lancet market is on track to achieve its projected USD ...

Samsung's senior vice president Hon Pak briefly highlighted the company's work at developing non-invasive glucose monitoring.

Samsung hints at a game-changing non-invasive blood glucose monitor for a future Galaxy Watch, potentially revolutionizing ...

Samsung is reportedly working on a revolutionary feature in wearable technology: non-invasive blood glucose monitoring.